InvestorsHub Logo
Followers 1
Posts 757
Boards Moderated 0
Alias Born 12/07/2003

Re: None

Sunday, 12/07/2003 12:59:14 PM

Sunday, December 07, 2003 12:59:14 PM

Post# of 82595
First post...??? on OVANOME classifier.

Although this is my first post, I've enjoyed reading the thread for the past month or so!

I have purchased DNAP shares over the past 30 days and believe I'll be buying more this week. As you know, their story is truly compelling and I "hope" that their proprietary items realize the value that we think they should!

OVANOME: what's the latest on this? The last info I can locate is the 12-02 newsletter from Tony. It states "We are in the process of executing a blind validation of OVANOME performance.....we could have our first drug classifier product on the market soon". Prior to that, is the 3-14-02 PR on the positive results reported at BioITWorld Expo in Boston.

If effective, IMO, this will be a huge coming out party for DNAP in the personalized medicine arena. I could see them charging $1,000+ for this test. Are yearly diagnoses around 14,000 for ovarian cancer? If so, at 50% testing = $7 mill annual revenues! ($3.5M to $5M profits?)

I apologize for asking for info that's probably been discussed before! TIA as I'll be posting lightly on my 3 alloted posts for today!

Mike